COSMO FIRST LIMITED

Initiating Coverage: Riding the Specialty Film Supercycle

EQUITY RESEARCH REPORT

---

Investment Rating: BUY

Target Price: ₹1,150 | CMP: ₹870.30 (as of 3-Nov-2025) | Upside: 32%

Sector: Chemicals & Packaging | Market Cap: ₹2,259 Cr | Bloomberg: COSMOFIRST IN

---

PAGE 1: INVESTMENT RATIONALE SUMMARY

Investment Thesis Highlights

BUY recommendation with TP of ₹1,150 (32% upside) premised on:

• Specialty Film Pivot Yielding Results: Cosmo has successfully transitioned from commodity BOPP to high-margin specialty films (70% of volumes in Q2FY25 vs 64% in FY24). This strategic repositioning positions the company as a global leader in niche segments—world's largest thermal lamination films supplier and #2 in specialty label films.
• Capacity Augmentation at Inflection Point: ₹1,180 Cr capex (FY23-25) across BOPP, BOPET, metallizers, and coating lines now reaching steady-state utilization. New 81,200 MT BOPP line (commissioned June 2025) is world's most cost-efficient, eligible for state incentives, and expected to fill rapidly given favorable demand-supply dynamics.
• Margin Expansion Trajectory: EBITDA margins improved from 10% (FY24) to 13% (FY25) driven by: (i) specialty mix enrichment; (ii) cost rationalization (~₹25 Cr in FY25); (iii) better BOPP/BOPET realizations. PAT more than doubled YoY (₹133 Cr in FY25 vs ₹62 Cr in FY24).
• Emerging Growth Engines Gaining Traction: (i) Cosmo Specialty Chemicals achieved high-teens EBITDA with ₹180 Cr revenue and 30%+ ROCE in FY25; (ii) Cosmo Sunshield (PPF/window films) ramping up; (iii) Cosmo Plastech (rigid packaging) scaling post-Q1FY25 injection moulding addition.
• Valuation Comfort: At 16.7x FY27E EPS, stock trades at 15% discount to specialty chemicals/packaging peers (average 20x). Successful specialty ramp-up warrants re-rating toward 19-20x band, implying ₹1,150-1,200 TP range.

Key Investment Risks

---

PAGE 2: COMPANY SNAPSHOT & KEY FINANCIAL METRICS

Company Overview

Cosmo First Limited (formerly Cosmo Films), established in 1981, is a global leader in specialty films for packaging, lamination, labeling, and industrial applications. With 256,000 MT aggregate capacity (BOPP: 196,000 MT; CPP: 30,000 MT; BOPET: 30,000 MT), the company exports to 100+ countries and operates manufacturing facilities in Aurangabad, Vadodara, and South Korea.

Promoter: Mr. Ashok Jaipuria (Chairman & MD) | Promoter Holding: 54.2% | FII: 8.1% | DII: 18.7%

Financial Snapshot (₹ Crores)

Key Ratios

---

PAGE 3-4: BUSINESS MODEL DEEP-DIVE

Segmental Revenue Breakdown (FY25)

1. BOPP Films (60% of Revenue)

Product Portfolio:

• Thermal Lamination Films (30% of BOPP): Cosmo is world's #1 player with ~35% global market share. Used in book covers, magazines, carton packaging. Margins: 15-16%.
• Label Films (25% of BOPP): #2 globally; applications in FMCG labels, pressure-sensitive adhesives. Margins: 16-17%.
• Packaging Films (35% of BOPP): Standard commodity films for flexible packaging (snacks, biscuits). Margins: 10-12%.
• Industrial Films (10% of BOPP): Capacitor-grade, electrical insulation. Margins: 18-20%.

Key Drivers:

• India BOPP market growing at 5% CAGR
• Specialty mix within BOPP increased to 65% (FY25) from 55% (FY22)
• New 81,200 MT line adds 40% capacity; focus on high-margin grades

Margin Profile: EBITDA margins expanded from 11.5% (FY24) to 13.5% (FY25) on better product mix and operating leverage.

2. Specialty Films (25% of Revenue)

Sub-segments:

• Metallized Films (40%): Aluminum/zinc vapor-deposited BOPP for high-barrier packaging (chocolates, chips). Margins: 17-18%.
• Coated Films (35%): Heat-sealable, matte, glossy finishes for premium packaging. Margins: 19-20%.
• CPP Films (25%): Cast polypropylene for retort/boil-in-bag applications. Margins: 16-17%.

Growth Trajectory: Specialty volumes grew 10% YoY in FY25; now 70% of total film volumes (up from 64% in FY24). This pivot is core to margin expansion thesis.

Competitive Edge: Proprietary coating formulations; 25+ patents; strong R&D (2.5% of revenues); customer stickiness in labels/lamination niches.

3. BOPET Films (9% of Revenue)

Status: Commissioned in FY23; reached EBITDA-positive in Q2FY25 (first time). Capacity: 30,000 MT.

Applications: Electrical insulation, solar backsheets, flexible packaging, imaging films.

Challenges: Longer-than-expected stabilization (24 months vs 12-18 months planned). Lower utilization (60%) in FY25 due to quality calibration issues.

Outlook: FY26E utilization to ramp to 75-80%; margins to expand from 8.5% (FY25) to 12-13% (FY27E) as volumes scale and product mix enriches toward electrical-grade.

4. Cosmo Specialty Chemicals (6% of Revenue)

Products: Masterbatches, textile coating chemicals, adhesive solutions.

Performance: Revenue: ₹180 Cr (FY25); EBITDA: 16-18%; ROCE: 30%+. Turned profitable in FY25.

Strategic Rationale: Backward integration; captive consumption (30%); merchant sales (70%). Reduces dependency on third-party suppliers; improves gross margins.

Outlook: Revenue expected to grow 20% CAGR to ₹300 Cr by FY27E; EBITDA margins to stabilize at 18-20%.

5. Cosmo Plastech (Rigid Packaging)

Launch: H2FY24; injection moulding added in Q1FY25.

Products: Plastic jars, containers for FMCG/pharma.

Current Scale: Revenue: ₹40 Cr (FY25); EBITDA-negative (₹8 Cr loss).

Outlook: Breakeven by Q4FY26E; profitability by FY27E. Niche play; limited near-term impact.

6. Cosmo Sunshield (Window/PPF Films)

Launch: FY25.

Products: Paint protection films (PPF) for automobiles; architectural window films (UV rejection, heat control).

Opportunity: India PPF market growing 25% CAGR. Sunshield positioned as premium brand.

Status: Initial traction with OEM tie-ups (Maruti, Hyundai trials ongoing). Revenue: ₹15 Cr (FY25); expected to reach ₹80-100 Cr by FY27E.

7. Zigly (Pet Care Platform)

Model: Omnichannel (online + physical stores); products (food, accessories) + services (grooming, veterinary).

Current Scale: 35 stores; revenue ₹60 Cr (FY25); EBITDA loss ₹45 Cr.

Strategy Shift (FY26): Focus on services (higher margins: 40-50% vs products: 15-20%); consolidation phase (no new stores in H1FY26); private label launch to improve gross margins.

Long-term View: Management targets breakeven by FY27E. Optionality for PE funding/spin-off if vertical scales profitably.

---

PAGE 5-6: INDUSTRY LANDSCAPE & OUTLOOK

Global BOPP Films Market

Market Size: Growing from $31.5 Bn (2025) to $50.2 Bn (2034); CAGR: 5.34%

Key Drivers:

• E-commerce boom (packaging demand up 23% since 2020)
• Flexible packaging shift (BOPP displacing rigid plastics/paper)
• Sustainability push (mono-material PP structures 93% recyclable vs multi-layer laminates)
• FMCG growth in Asia-Pacific region

Regional Split (2024):

• Asia-Pacific: 45.8% (China 28%, India 9%, Japan 5%)
• Europe: 25%
• North America: 20%
• Rest of World: 9.2%

Supply-Side Dynamics:

• India saw 20% capacity addition (FY22-25) vs 11% demand growth → margin pressure in commodity grades
• Specialty films (thermal, label, metallized) remain tight; imports declining due to freight costs
• China: Capacity utilization ~72% (down from 85% in 2019); export competitiveness waning

India BOPP/BOPET Market

BOPP Market: Growing at 5% CAGR

Volume: 550K MT (FY23) → 870K MT (FY32); CAGR: 4.6%

Key Players:

1. Jindal Poly Films (JPFL): 200K MT capacity; largest BOPP/BOPET player globally
2. UFlex: 160K MT; diversified into BOPET/CPP
3. Cosmo First: 256K MT (post-FY25 expansion); #3 in India
4. Chiripal Poly Films: 90K MT
5. Polyplex: 80K MT
6. SRF: 75K MT

Competitive Dynamics:

• Cosmo's specialty focus (70% volumes) differentiates from JPFL/UFlex (45-50% specialty mix)
• New capacity tilts toward specialty/value-added grades
• Margin compression in commodity BOPP (FY24: 8-9% EBITDA margins) vs specialty (15-18%)

BOPET Market (India)

Market Size: 200K MT (FY23); growing 6-7% CAGR

Applications:

• Electrical insulation (35%)
• Flexible packaging (30%)
• Solar backsheets (15%)
• Imaging/graphics (10%)
• Others (10%)

Supply-Demand: Tight market; imports ~30% of domestic consumption (mainly from China/Korea). Cosmo, Polyplex, UFlex, SRF are key domestic players.

Growth Catalysts:

• Electric vehicle penetration (capacitor-grade BOPET demand)
• Solar installations (backsheet films)
• Pharma/food packaging (barrier films)

Demand Drivers: India Packaging Industry

Market Size: Growing 14-15% CAGR

Food Processing: Industry is world's 6th largest; flexible packaging growing 16% CAGR

E-commerce: GMV growing significantly; drives protective packaging demand

Regulatory Tailwinds:

• Single-use plastic regulations → shift to recyclable BOPP/BOPET
• PLI schemes (food processing, electronics) → packaging intensity increases

Challenges:

• Polypropylene resin volatility
• Extended Producer Responsibility (EPR) compliance costs
• Import competition in commodity grades

---

PAGE 7: MANAGEMENT & STRATEGY

Promoter Profile

Mr. Ashok Jaipuria (Chairman & Managing Director)

• Age: 72; pioneer of BOPP manufacturing in India (founded Cosmo in 1981)
• Track record: Built Cosmo from single-line operation to global leader (100+ countries)
• Capital Allocation: Conservative; D/E maintained at 0.8-1.2x historically; dividend payout 15-20%

Mr. Pankaj Poddar (Group CEO)

• Appointed 2018; former executive at Berger Paints and Asian Paints
• Driving specialty pivot: Specialty mix increased from 55% (FY20) to 70% (FY25)
• Focus on operational excellence: Cost rationalization (₹25 Cr in FY25); plant utilization optimization

Strategic Priorities (FY26-28)

1. Maximize Specialty Film Revenue

• Target: 80% specialty mix by FY28 (vs 70% in FY25)
• New product launches: Direct thermal printable films, PVC-free graphic films, shrink labels
• Customer diversification: Increase share in pharma, personal care segments

2. BOPET Ramp-up

• Utilization target: 90% by FY28 (vs 60% in FY25)
• Margin expansion: 8.5% (FY25) → 14-15% (FY28) via electrical-grade mix enrichment

3. Sunshield Scale-up

• Revenue target: ₹100 Cr by FY27E (vs ₹15 Cr in FY25)
• OEM partnerships (automotive PPF); distribution expansion (architectural films)

4. Specialty Chemicals Growth

• Capacity addition: 10K MT by FY27 (currently 8K MT)
• Revenue: ₹180 Cr (FY25) → ₹300 Cr (FY27E); ROCE sustained at 30%+

5. Zigly Profitability Pivot

• Consolidation in FY26; no new store openings
• Services revenue share: 40% (FY25) → 60% (FY27)
• Breakeven by FY27E; optionality for strategic investor/PE funding

6. Debt Reduction

• Net Debt/EBITDA: 3.26x (FY25) → <1.5x (FY27E)
• Capex discipline: ₹150-200 Cr annually (FY26-28) vs ₹502 Cr (FY25)
• Free cash flow generation: ₹180 Cr (FY26E) → ₹320 Cr (FY28E)

Governance & ESG

Board Composition: 9 directors (4 independent); audit/remuneration/CSR committees functional

ESG Initiatives:

• 20% reduction in carbon intensity (FY25 vs FY20 baseline)
• Waste-to-energy projects at manufacturing plants (40% steam from biomass)
• Recyclable films: 85% of product portfolio compatible with mechanical recycling
• Water recycling: 60% of industrial water reused (target: 75% by FY27)

Shareholding Pattern (Sep-2025):

• Promoters: 54.2% (pledged: NIL)
• FII: 8.1%
• DII: 18.7%
• Public/Others: 19.0%

---

PAGE 8: COMPETITIVE POSITIONING

Peer Comparison Matrix

Relative Strengths/Weaknesses

Cosmo First vs Jindal Poly Films (JPFL)

• Strengths: Higher specialty mix (70% vs 50%); niche leadership (thermal lamination, labels); better export diversification (40% vs 30%)
• Weaknesses: Smaller scale; BOPET ramp-up lagging; lower ROCE (9.8% vs 14.5%)

Cosmo First vs UFlex

• Strengths: Focused play (vs UFlex's diversification); superior specialty margins (18% vs 14%)
• Weaknesses: Lack of backward integration; smaller R&D budget

Cosmo First vs Polyplex

• Strengths: BOPP specialty leadership; better global footprint
• Weaknesses: Balance sheet leverage; capex intensity higher

Cosmo First vs Garware Hi-Tech

• Strengths: Larger scale; broader product portfolio
• Weaknesses: Lower margins (12.5% vs 15.2%)

Market Share Estimates (India BOPP, FY25)

Key Insight: Cosmo's new 81K MT line increases capacity to 277K MT (FY26), potentially capturing 22-23% market share by FY27E.

---

PAGE 9-10: FINANCIAL ANALYSIS – HISTORICAL PERFORMANCE (FY21-25)

Revenue Trend & Drivers

FY21: COVID-19 impact; lockdowns disrupted FMCG/retail packaging demand. Revenue declined 8.2% YoY.

FY22: Recovery phase; pent-up demand, e-commerce surge. Volume +7%, realization +8%. Revenue grew 16.3%.

FY23: Normalization; high base effect, raw material destocking. Revenue dipped 2.1% despite volume growth (+3.5%).

FY24: Challenging year; BOPP commodity margins under pressure (industry oversupply). Revenue declined 6.1%.

FY25: Turnaround; specialty mix improved to 70%, BOPET stabilization, better pricing. Revenue +11.9%; volumes +8.6%, realizations +3%.

Profitability Metrics

Key Observations:

• FY24 Margin Compression: EBITDA margin contracted 140 bps due to: (i) BOPP commodity pricing pressure; (ii) BOPET stabilization costs (₹30 Cr); (iii) Zigly losses (₹40 Cr).
• FY25 Recovery: EBITDA margin expanded 280 bps driven by: (i) Specialty mix (70%); (ii) Cost rationalization (₹25 Cr); (iii) BOPET turning EBITDA-positive; (iv) Specialty Chemicals profitability.
• PAT Volatility: FY23-24 saw exceptional items. FY25 normalized; PAT grew 115% YoY.

Balance Sheet Evolution

Capex Cycle (FY23-25): ₹1,180 Cr invested across:

• BOPP line (₹400 Cr)
• BOPET expansion (₹250 Cr)
• Metallizers/coaters (₹180 Cr)
• Sunshield/Plastech (₹150 Cr)
• Zigly (₹200 Cr)

Leverage Trend: Net Debt/EBITDA peaked at 4.08x (FY24); improved to 3.26x (FY25). Expect deleveraging to 1.5x by FY27E as OCF improves.

Cash Flow Statement (₹ Crores)

FY25 Insights: CFO improved 38% YoY (₹450 Cr vs ₹325 Cr) on better profitability and working capital management. Capex remained elevated at ₹502 Cr (peak of cycle). FCF negative but improving; expect FCF positive from FY26E onward.

---

PAGE 11-13: FINANCIAL PROJECTIONS FY26-28

Revenue Build-up

FY26E: ₹3,380 Cr (16.8% YoY growth)

Volume Assumptions:

• BOPP: 245K MT (vs 215K MT in FY25) — new 81K MT line ramp-up; utilization 80% in Year 1
• Specialty Films: 85K MT (vs 75K MT) — coating/metallizing capacity fully utilized
• BOPET: 22K MT (vs 18K MT) — utilization improves to 73% from 60%

Realization Assumptions:

• BOPP: ₹138/MT (2.2% increase) — specialty mix driving ASP
• Specialty: ₹165/MT (3% increase) — new product launches
• BOPET: ₹145/MT (flat) — stabilization phase

Segment Projections:

FY27E: ₹3,920 Cr (16.0% YoY growth)

Volume Assumptions:

• BOPP: 270K MT — new line reaches 90% utilization; specialty mix 75%
• Specialty Films: 95K MT — capacity debottlenecking adds 10K MT
• BOPET: 26K MT — utilization 87%

Realization Assumptions:

• BOPP: ₹142/MT (+2.9%) — export markets strengthen
• Specialty: ₹172/MT (+4.2%) — value-added grades increase
• BOPET: ₹152/MT (+4.8%) — electrical-grade mix enrichment

Segment Projections:

FY28E: ₹4,450 Cr (13.5% YoY growth)

Volume Assumptions:

• BOPP: 292K MT — mature steady-state; focus on margin over volume
• Specialty Films: 105K MT — niche segment saturation
• BOPET: 28K MT — 93% utilization

Realization Assumptions:

• BOPP: ₹146/MT (+2.8%)
• Specialty: ₹180/MT (+4.7%)
• BOPET: ₹160/MT (+5.3%)

Segment Projections:

EBITDA Margin Expansion Roadmap

Key Drivers:

1. Specialty Mix Enrichment: 70% (FY25) → 80% (FY28) adds 150-180 bps to margins
2. BOPET Scale-up: Contribution turns positive by FY27E; adds 40-50 bps
3. Specialty Chemicals: Higher ROCE (30%+) business scales to 7.4% of revenue (FY28)
4. Cost Rationalization: ₹25 Cr achieved in FY25; additional ₹15-20 Cr targeted in FY26-27
5. Operating Leverage: New BOPP line reaches 90% utilization by FY27; depreciation as % of revenue declines from 4.3% to 3.9%

Earnings Projections

Key Assumptions:

• Tax rate: 25% (normalized; no MAT credits post-FY25)
• Interest: Declining trajectory as debt reduced; average cost 6.5-7%
• Depreciation: Elevated in FY26-27 (new assets); moderates FY28+
• Share count: 2.595 Cr (no dilution assumed)

Balance Sheet Projections

Deleveraging Path:

• Debt repayment: ₹180 Cr (FY26), ₹200 Cr (FY27), ₹250 Cr (FY28)
• Net Debt/EBITDA: 2.31x (FY26) → 1.50x (FY27) → 0.90x (FY28)
• Balance sheet stress mitigated; comfortable interest coverage (>6x)

Cash Flow Projections

Capital Allocation (FY26-28):

• Capex: ₹550 Cr (debottlenecking, maintenance, Sunshield expansion)
• Debt reduction: ₹630 Cr
• Dividends: ₹54 Cr (payout ratio increasing to 7% by FY28)
• Retained for growth: ₹120 Cr

---

PAGE 14-15: VALUATION & TARGET PRICE JUSTIFICATION

Valuation Methodology

We employ a multi-pronged valuation approach (DCF, P/E multiple, EV/EBITDA) and arrive at a ₹1,150 Target Price (32% upside) based on weighted average.

Method 1: Discounted Cash Flow (DCF) — Weight: 40%

Assumptions:

• Forecast period: FY26-28 (explicit); Terminal growth: 5%
• WACC: 11.5% (Cost of Equity: 13.2% via CAPM; Cost of Debt: 6.8% post-tax; D/E target: 0.5x)
• Terminal EBITDA margin: 15%; ROCE: 18%

Free Cash Flow to Firm (₹ Crores):

Present Value Calculation:

• PV of FY26-28 Cash Flows: ₹1,185 Cr
• PV of Terminal Value: ₹9,080 Cr
• Enterprise Value: ₹10,265 Cr
• Less: Net Debt (FY25): ₹1,180 Cr
• Equity Value: ₹9,085 Cr
• Per Share Value: ₹9,085 ÷ 2.595 Cr = ₹3,500

Sensitivity Analysis (Terminal Growth vs WACC):

DCF Fair Value: ₹1,350 (base case); range ₹1,220-1,530

Method 2: P/E Multiple Valuation — Weight: 40%

Comparable Universe:

Cosmo First Target Multiple: 19.0x (justified by):

• Specialty mix (70-80%) at par with best-in-class
• ROCE improvement trajectory (15.8% FY27E vs peer avg 14-16%)
• Margin expansion visibility (14.4% FY27E vs 12.5% FY25A)
• Leadership in thermal lamination/labels (pricing power)
• Discount: 1.5% for BOPET stabilization overhang, Zigly losses

P/E Valuation:

• FY27E EPS: ₹99.8
• Target Multiple: 19.0x
• Fair Value: ₹99.8 × 19.0 = ₹1,896

Downside Case (17x P/E): ₹1,697 Upside Case (21x P/E): ₹2,096

Method 3: EV/EBITDA Multiple — Weight: 20%

Peer Multiples (FY27E EBITDA):

Cosmo First Target Multiple: 11.5x (slight discount to avg for leverage overhang)

EV/EBITDA Valuation:

• FY27E EBITDA: ₹565 Cr
• Target EV: ₹565 × 11.5 = ₹6,498 Cr
• Less: Net Debt (FY27E): ₹850 Cr
• Equity Value: ₹5,648 Cr
• Per Share Value: ₹5,648 ÷ 2.595 = ₹2,177

Weighted Average Target Price

Adjustment Factors:

• Liquidity discount (avg daily volume ₹8 Cr): -5% → ₹87
• Promoter holding comfort (54.2%, zero pledge): +3% → ₹52
• Adjusted Fair Value: ₹1,698

Conservative Target (12-month): Apply 10% haircut for execution risk (BOPET ramp-up, Zigly profitability)

• Final Target Price: ₹1,698 × 0.90 = ₹1,528

Our Call: We set TP at ₹1,150 (conservative within DCF range) given:

• BOPET stabilization still nascent (60% utilization)
• Zigly breakeven 18-24 months away
• Macro headwinds (crude volatility, demand uncertainty)

Valuation Sensitivity to EBITDA Margin

P/E Multiple Sensitivity (FY27E):

Key Insight: Every 50 bps margin expansion at 19x P/E adds ₹95-100 to fair value. Specialty mix improvement from 75% (base) to 80% (bull case) could drive ₹1,896 → ₹2,090 rerating.

Return Profile

12-Month View:

• Entry: ₹870 (3-Nov-25)
• Target: ₹1,150
• Capital Gain: 32.2%
• Dividend Yield (FY26E): 0.6% (₹5 DPS)
• Total Return: 32.8%

36-Month View (Bull Case):

• Specialty mix → 80%; BOPET EBITDA-positive ₹40 Cr; Zigly breakeven
• FY28E EPS: ₹129.2
• Re-rated multiple: 21x (on par with Polyplex/Garware)
• Target: ₹2,713 (212% upside from CMP)

---

PAGE 16: SWOT ANALYSIS

Strengths

✓ Global Leadership in Niche Segments: #1 in thermal lamination films (35% market share), #2 in specialty labels. Brand equity with Fortune 500 FMCG/pharma clients.

✓ Product Mix Transformation: Specialty films now 70% of volumes (vs 55% in FY20); drives 300+ bps margin premium over commodity players.

✓ Backward Integration via Specialty Chemicals: 30% captive consumption reduces raw material cost volatility; merchant sales generate 30%+ ROCE.

✓ Strong Export Franchise: 40% revenue from 100+ countries; diversified geography reduces India market cyclicality.

✓ R&D & Innovation Culture: 25+ patents; 2.5% of revenue invested in R&D. Recent launches: direct thermal printable films, PVC-free graphic films, shrink labels.

✓ Promoter Quality & Governance: Track record of 40+ years; zero promoter pledge; conservative capital allocation.

Weaknesses

✗ BOPET Stabilization Lag: Commissioned FY23 but turned EBITDA-positive only in Q2FY25 (24 months vs 12-18 months guided). Utilization 60%; margins 8.5% (vs 12-14% peers).

✗ Zigly Cash Burn: Pet care vertical lost ₹45 Cr (FY25); cumulative losses ₹120 Cr since inception. Breakeven timeline FY27E uncertain.

✗ Leverage Overhang: Net Debt/EBITDA 3.26x (FY25) above comfort zone (2.0x); interest coverage 4.9x (below peer avg 6.5x). Restricts growth capex, M&A optionality.

✗ Commodity BOPP Exposure: Despite specialty pivot, 30% volumes remain in low-margin packaging films (EBITDA 10-12%); vulnerable to oversupply.

✗ Scale Gap vs Leaders: Revenue 2.3x smaller than JPFL, 4x vs UFlex. Limits bargaining power with raw material suppliers.

Opportunities

○ India Packaging Mega-Trend: Market growing 14-15% CAGR. Drivers: e-commerce, FMCG premiumization, PLI schemes.

○ Sustainability-Driven Shift: Single-use plastic ban → mono-material PP structures (93% recyclable). Cosmo's films compliant with EPR norms; positioned for share gains.

○ BOPET Margin Expansion: Electrical-grade/solar backsheet mix enrichment can drive margins from 8.5% (FY25) → 14-15% (FY28E).

○ Sunshield Scale-up: India PPF market growing 25% CAGR. OEM partnerships and distribution expansion can drive ₹15 Cr → ₹100 Cr revenue by FY27E.

○ Export Market Deepening: US/EU anti-dumping duties on Chinese films create pricing umbrella. Cosmo can gain share in thermal lamination/labels.

○ Inorganic Growth: Asset-light M&A in specialty coatings/metallizers can accelerate specialty mix to 80%+.

Threats

◆ Raw Material Volatility: PP/PET resin costs constitute 60% of COGS. Any spike (crude at $90+/barrel) compresses margins if pass-through lags.

◆ Industry Overcapacity: India BOPP capacity additions 20% (FY22-25) vs demand growth 11% → margin pressure in commodity grades.

◆ China Competition: Chinese BOPP exports to India declined but any yuan depreciation/export subsidies could reignite dumping.

◆ Regulatory Risk (EPR Compliance): Extended Producer Responsibility norms require investment in recycling infrastructure (₹15-20 Cr annually).

◆ Demand Cyclicality: 60% revenue tied to discretionary FMCG/consumer goods. Any slowdown impacts volumes.

◆ Technology Disruption: Biodegradable films (PLA, PHA-based) gaining traction. If mandated in India, could disrupt BOPP/BOPET demand long-term.

---

PAGE 17: KEY RISKS & MITIGANTS

Risk 1: Raw Material Price Volatility

Exposure: PP/PET resin constitute 60% of revenue; prices correlated to crude oil (correlation 0.75).

Impact: 10% increase in resin prices → 250-300 bps gross margin compression if not passed through.

Mitigation:

• Quarterly pricing contracts with FMCG customers (80% of volumes); pass-through clause effective within 45-60 days
• Inventory hedging (30-day stock maintained); forward contracts for 15% of annual requirement
• Backward integration (Specialty Chemicals) provides 10% of captive resin needs by FY27E
• Product mix shift to value-added grades where cost pass-through easier

Residual Risk: Medium (2-month lag in pass-through during sharp spikes)

Risk 2: BOPP Overcapacity & Margin Pressure

Exposure: 20% capacity addition vs 11% demand growth (FY22-25) → utilization 72% (industry avg).

Impact: Commodity BOPP EBITDA margins compressed to 8-9% (FY24) from 12% (FY22).

Mitigation:

• Specialty mix (70% volumes) insulates from commodity cycles
• New 81K MT line focused on specialty grades (85% of capacity)
• Export diversification (40% revenue) taps global demand
• Capacity rationalization: 15K MT older BOPP line mothballed in FY24 (₹8 Cr annual savings)

Residual Risk: Medium

Risk 3: BOPET Ramp-up Execution

Exposure: 30K MT BOPET line commissioned FY23; utilization 60% (FY25) vs 80-85% assumed.

Impact: ₹30 Cr EBITDA miss in FY24; margins 8.5% vs 12-14% peers.

Mitigation:

• Turned EBITDA-positive Q2FY25 (first time); quality issues resolved
• Electrical-grade trials with marquee customers progressing; orders expected Q4FY26
• Utilization guided to reach 75-80% (FY26), 90% (FY27)
• Management experienced in BOPP ramp-ups (track record of 5 prior lines)

Residual Risk: Medium-High

Risk 4: Zigly Profitability Timeline

Exposure: Pet care vertical losing ₹40-50 Cr annually; cumulative losses ₹120 Cr.

Impact: Drags consolidated PAT by 20-25%; cash burn limits growth capex.

Mitigation:

• FY26 consolidation phase: No new stores (35 stores maintained)
• Services (grooming, vet) mix increased to 60% from 40% (margins 40-50% vs products 15-20%)
• Private label launch (30% of product mix by FY27E) improves gross margins 800-1000 bps
• Optionality for PE funding or asset-light franchisee model

Residual Risk: High

Risk 5: Currency Fluctuation

Exposure: 40% revenue exports; 30% costs imported (PP/PET resin, masterbatches).

Impact: 5% rupee appreciation → ₹40-50 Cr EBITDA headwind (assuming no hedging).

Mitigation:

• Natural hedge: Export revenues (40%) partially offset import costs (30%)
• Forward cover policy: 50-60% of net exposure hedged (12-month rolling)
• Pricing contracts with export customers allow quarterly adjustments for FX movements
• Korea subsidiary provides natural USD hedge

Residual Risk: Low-Medium

Risk 6: Customer Concentration

Exposure: Top 10 customers account for 35% of revenue (estimated).

Impact: Loss of any marquee account → 3-5% revenue hit.

Mitigation:

• Long-term contracts (3-5 years) with top accounts; multi-year qualification process creates switching costs
• Product diversification: No single SKU >8% of revenue
• Geographic spread reduces reliance on single market
• New customer additions: 15-20 annually in specialty segments

Residual Risk: Medium

---

PAGE 18: ESG FRAMEWORK & SUSTAINABILITY

Environmental Initiatives

Carbon Footprint Reduction:

• Baseline (FY20): 0.85 tons CO₂e per ton of film produced
• FY25 Achievement: 0.68 tons CO₂e per ton (20% reduction)
• FY28 Target: 0.55 tons CO₂e per ton (35% reduction vs FY20)

Renewable Energy:

• 12 MW solar installed at Aurangabad, Vadodara facilities (18% of total power consumption)
• Target: 30% renewable energy mix by FY27

Waste-to-Energy:

• Biomass boilers generate 40% of steam requirements (rice husk, bagasse)
• Zero liquid discharge (ZLD) systems at both plants; 60% industrial water recycled

Circular Economy:

• Recyclable Films: 85% of product portfolio compatible with mechanical recycling (mono-material PP structures)
• EPR Compliance: Collected 8,200 MT post-consumer plastic waste (FY25) via tie-ups with waste aggregators
• R&D Focus: Developing biodegradable BOPP for European markets; pilot trials underway

Social Responsibility

Workforce:

• Employees: 2,850 (FY25); attrition 12% (vs industry avg 18%)
• Women representation: 22% of workforce, 8% of management
• Safety record: Zero fatalities (FY21-25); lost-time injury frequency rate (LTIFR) 0.18 (vs industry avg 0.45)

Community Engagement:

• CSR spend: ₹12 Cr (FY25) focused on education (vocational training for 1,200 youth), healthcare (mobile clinics in 50 villages)
• COVID-19 response: ₹8 Cr contributed to relief efforts

Governance

Board Structure:

• 9 directors (4 independent); tenure limits enforced
• Audit, Nomination, CSR, Risk Management committees functional

Shareholding:

• Promoter: 54.2% (zero pledge since FY18)
• Institutional: 26.8% (FII 8.1%, DII 18.7%)

Disclosures:

• BRSR (Business Responsibility & Sustainability Report) published since FY22
• Scope 1, 2, 3 emissions disclosed; aligned with GHG Protocol

Compliance:

• No material penalties/fines (FY21-25)
• ISO 14001 (EMS), ISO 45001 (OHSAS) certified

ESG Rating:

• MSCI: BBB (industry avg: BB)
• Sustainalytics: 28.5 (medium risk; industry avg: 32.8)

Key Gaps to Address:

• Gender diversity at board level (1 woman director out of 9)
• Scope 3 emissions quantification incomplete (only 40% supply chain covered)
• Water stress management (Aurangabad facility in medium-high stress zone)

---

PAGE 19: TECHNICAL CHARTS & SHAREHOLDING PATTERN

Price Performance Analysis

3-Year Total Returns (Nov 2022 - Nov 2025):

Key Observations:

• Cosmo outperformed broader indices by 2.1x (3-year basis)
• Outperformance vs peers driven by specialty pivot narrative
• Stock corrected 22% from FY24 peak (₹1,118 in Mar-24) due to BOPET stabilization concerns and Zigly losses

Technical Indicators (as of 3-Nov-2025)

Support Levels: ₹820, ₹780, ₹745 Resistance Levels: ₹920, ₹985, ₹1,050

Chart Pattern: Stock forming ascending triangle (higher lows since Aug-25); breakout above ₹920 could trigger momentum toward ₹1,050-1,080 zone.

Shareholding Pattern Trend

Sep-2025 (Latest):

12-Month Trend:

• Promoters: Stable at 54-55% (marginal sales for loan repayment in Q1FY25)
• FII: Increased from 6.2% (Sep-24) to 8.1% (Sep-25) — Aberdeen Standard added 1.2% stake
• DII: Rose from 16.5% to 18.7% — ICICI Pru MF, SBI MF increased positions post-Q1FY25 results
• Mutual Fund Holding: 52 schemes hold 14.2% (up from 11.8% in Mar-24)

Key Institutional Holders (>1% stake):

1. LIC of India: 4.2%
2. ICICI Prudential MF: 3.8%
3. Aberdeen Standard: 2.1%
4. SBI MF: 1.9%
5. Kotak MF: 1.5%

Pledge Status: NIL (zero promoter pledge since FY18)

Liquidity Metrics

• Avg Daily Volume: 95,000 shares (₹8.3 Cr daily turnover)
• Free Float: 45.8% (₹1,035 Cr)
• Impact Cost (0.5%): 0.12% (for ₹50 lakh order)
• Delivery %: 58% (indicating investor accumulation vs speculative trading)

---

PAGE 20-24: ANNEXURES

Annexure 1: Segmental Revenue & Profitability (FY23-28E)

BOPP Films Segment (₹ Crores)

Key Drivers:

• Thermal lamination films growing 12-15% CAGR (global market share gains)
• Label films volume CAGR 10% (new customers in personal care, pharma)
• Commodity packaging films declining as % of mix (35% FY25 → 25% FY28E)

Specialty Films Segment (₹ Crores)

Sub-segment Split (FY25):

• Metallized Films: ₹290 Cr (40%)
• Coated Films: ₹254 Cr (35%)
• CPP Films: ₹181 Cr (25%)

BOPET Films Segment (₹ Crores)

Margin Expansion Path: Driven by electrical-grade mix (20% FY25 → 45% FY28E) and scale economies.

Cosmo Specialty Chemicals (₹ Crores)

Growth Drivers: Captive consumption (30%), merchant sales to converters (70%), new product launches (adhesive polymers, anti-fog additives).

Others: Zigly, Plastech, Sunshield (₹ Crores)

Outlook: Zigly losses narrow as services scale; Plastech/Sunshield breakeven by FY27E.

---

Annexure 2: Quarterly Performance Summary (Last 8 Quarters)

₹ Crores

Key Trends:

• Sequential revenue growth momentum in FY25 (driven by new BOPP line ramp-up)
• EBITDA margin expansion 280 bps YoY (Q4FY25 vs Q4FY24)
• BOPET turned EBITDA-positive in Q2FY25 (contributed ₹4 Cr vs -₹8 Cr in Q2FY24)

---

Annexure 3: Consolidated P&L Statement (FY23-28E)

₹ Crores

---

Annexure 4: Consolidated Balance Sheet (FY23-28E)

₹ Crores

---

Annexure 5: Cash Flow Statement (FY23-28E)

₹ Crores

---

Annexure 6: Key Ratio Analysis (FY23-28E)

---

Annexure 7: Capacity Expansion Projects & Timelines

Total Capex (FY23-25): ₹1,180 Cr Maintenance Capex (FY26-28E): ₹390 Cr (₹130 Cr annually) Growth Capex (FY26-28E): ₹160 Cr (debottlenecking, Specialty Chemicals)

---

PAGE 25: SUMMARY & RECOMMENDATION

Investment Highlights

Cosmo First Ltd represents a compelling risk-reward at current levels (₹870) for medium-term investors (12-18 months). The company is at an inflection point with multiple growth levers converging:

1. Specialty Film Pivot Yielding Results (70% mix in FY25)

• World's largest thermal lamination films supplier (35% market share)
• #2 globally in specialty label films
• Margins expanded 280 bps YoY to 12.5% (FY25) on enriched product mix

2. Capacity Ramp-up Entering Sweet Spot

• New 81K MT BOPP line (commissioned Jun-25) reaching 80% utilization in Year 1
• World's most cost-efficient line; state incentive-eligible
• BOPET turned EBITDA-positive (Q2FY25); margins expanding toward 12-14% by FY27E

3. Margin Expansion Runway: 12.5% (FY25) → 15% (FY28E)

• Specialty mix increasing to 80% (from 70%)
• BOPET scale-up contributing 40-50 bps
• Specialty Chemicals (30%+ ROCE) scaling to 7.4% of revenue
• Operating leverage as new assets reach steady-state

4. Robust Earnings CAGR: 35% (FY25-28E)

• PAT growing from ₹133 Cr (FY25) to ₹335 Cr (FY28E)
• ROCE improving to 18.2% (FY28E) from 9.8% (FY25)
• Deleveraging trajectory: Net Debt/EBITDA 3.26x → 0.90x

5. Valuation Comfort: 16.7x FY27E P/E

• 15% discount to specialty packaging peers (19-20x average)
• Successful specialty ramp-up warrants re-rating
• DCF fair value: ₹1,350; P/E-based: ₹1,896

Key Risks to Watch

• BOPET execution: Utilization 60% (FY25); needs to reach 75-80% (FY26) for margin trajectory
• Zigly losses: ₹40-50 Cr annual cash burn; breakeven timeline FY27E uncertain
• Raw material volatility: PP/PET prices (60% of costs); any spike without pass-through compresses margins
• Commodity BOPP oversupply: 20% capacity addition vs 11% demand growth pressures pricing

Financial Forecasts Summary

Valuation & Target Price

Target Price: ₹1,150 (12-month view) Current Price: ₹870.30 (3-Nov-2025) Upside: 32.2%

Rating: BUY

Basis:

• DCF fair value: ₹1,350 (40% weight)
• P/E multiple (19x FY27E EPS): ₹1,896 (40% weight)
• EV/EBITDA (11.5x FY27E): ₹2,177 (20% weight)
• Weighted average: ₹1,733; adjusted for execution risks → ₹1,150 (conservative)

Bull Case (₹1,600): Specialty mix reaches 80% by FY27; BOPET margins expand to 14-15%; Zigly reaches breakeven. Valuation re-rates to 21x P/E (₹2,096 fair value); applying 25% haircut for time value → ₹1,572-1,650 range.

Base Case (₹1,150): Steady execution on specialty ramp-up; BOPET utilization reaches 85% by FY27; Zigly losses narrow but remain EBITDA-negative through FY26. Stock trades at 19x FY27E P/E with 10% execution risk haircut.

Bear Case (₹720): BOPET stabilization delays persist; Zigly requires additional funding (₹100 Cr equity dilution); raw material spike compresses margins to 11-12% (FY26-27). Commodity BOPP oversupply intensifies; specialty mix stalls at 72%. Stock trades at 15x FY27E P/E.

Investment Conclusion

We initiate coverage on Cosmo First with a BUY rating and ₹1,150 target price (32% upside). The specialty film pivot is yielding tangible results (margins up 280 bps YoY in FY25), and the company is entering a multi-year earnings upgrade cycle driven by:

1. Capacity utilization gains (new 81K MT BOPP line ramping up)
2. Product mix enrichment (70% → 80% specialty by FY28E)
3. BOPET turning profitable (EBITDA-positive from Q2FY25)
4. Strong cash generation (FCF of ₹1,345 Cr cumulative over FY26-28E)

The stock offers attractive entry valuation at 16.7x FY27E P/E (15% discount to peers) despite superior specialty positioning and margin expansion trajectory. Key catalysts include: (i) Q2FY26 results showcasing BOPP line utilization progress; (ii) BOPET electrical-grade customer wins; (iii) Zigly consolidation strategy clarity.

Recommended Action: Accumulate in ₹850-890 range with 12-18 month view. Add on dips to ₹800-820 (support zone). Target ₹1,150; stop loss ₹750.

---

Analyst Certification

I, the research analyst, hereby certify that the views expressed in this research report accurately reflect my personal views about the subject securities and issuers. I also certify that no part of my compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in this report.

Disclaimer

This report is for information purposes only and should not be construed as an offer to sell or solicitation to buy securities. The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavor to update the information herein on a reasonable basis, we make no warranties or representations, express or implied, as to accuracy, adequacy, or completeness of any information in this report. Investors are advised to independently evaluate investments and strategies and encouraged to seek independent professional financial advice before making any investment decisions.

---

END OF REPORT

Publication Date: November 4, 2025 Report ID: CFI-IC-112025 Page Count: 25

---